Skip to main content
Contact Us
Subscribe
E-Edition
62°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Valneva Se ADR
(NQ:
VALN
)
7.916
UNCHANGED
Streaming Delayed Price
Updated: 2:04 PM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
7.916
Bid (Size)
7.490 (32)
Ask (Size)
8.210 (13)
Prev. Close
7.916
Today's Range
7.916 - 7.916
52wk Range
6.390 - 14.49
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
ZIM Integrated Shipping Services Posts Upbeat Earnings, Joins fuboTV, Foghorn Therapeutics And Other Big Stocks Moving Higher On Monday
August 19, 2024
Via
Benzinga
Performance
YTD
-22.70%
-22.70%
1 Month
+4.57%
+4.57%
3 Month
-9.33%
-9.33%
6 Month
+9.18%
+9.18%
1 Year
-42.43%
-42.43%
More News
Read More
Analyst Scoreboard: 8 Ratings For Valneva
August 14, 2024
Via
Benzinga
What Analysts Are Saying About Valneva Stock
July 22, 2024
Via
Benzinga
The Analyst Landscape: 6 Takes On Valneva
June 24, 2024
Via
Benzinga
What Analysts Are Saying About Valneva Stock
May 31, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Valneva
May 08, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q2 2024
August 13, 2024
Via
InvestorPlace
3 Promising Biotech Stocks You Can Pick Up for Less Than $10
July 29, 2024
Via
InvestorPlace
Pfizer/Valneva's Vaccine Study For Tick-Borne Infection Completes Primary Vaccination Series, Plans Approval In 2026
July 18, 2024
Via
Benzinga
Valneva Seeks Expanded Use For Its Chikungunya Vaccine In Adolescents With Encouraging Phase 3 Data
May 13, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses EPS, Misses Revenue for Q1 2024
May 13, 2024
Via
InvestorPlace
What Analysts Are Saying About Valneva Stock
March 22, 2024
Via
Benzinga
VALN Stock Earnings: Valneva Misses Revenue for Q4 2023
March 20, 2024
Via
InvestorPlace
Expert Ratings for Valneva
December 04, 2023
Via
Benzinga
Analyst Ratings for Valneva
November 10, 2023
Via
Benzinga
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
March 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
March 08, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Novavax’s dispute resolution and upcoming earnings call
February 23, 2024
Via
MarketBeat
Topics
Earnings
Exposures
COVID-19
Financial
Analyst Ratings for Valneva
September 07, 2023
Via
Benzinga
Chikungunya Vaccine Maker Valneva Secures Non Dilutive Funding To Develop/Expand Its Clinical Pipeline
February 05, 2024
Via
Benzinga
Exposures
Product Safety
McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday
February 05, 2024
Via
Benzinga
Valneva Says Single Chikungunya Vaccine Shows Long-Lasting Antibody Response In Younger, Older Adults
December 04, 2023
Via
Benzinga
FDA Approves World's First Mosquito-Borne Chikungunya Vaccine
November 10, 2023
Via
Benzinga
Exposures
Product Safety
Pfizer, Valneva's Tick-Borne Infection Shot: Companies Say 'Positive' Result For Lyme Disease Vaccine Candidate Booster
September 07, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.